Samsung Bioepis Begins Denosumab Trials

Company Also Announces Successful Ranibizumab Phase III Trials And US Filing

 
• By Akriti Seth
Lab_Vials
Samsung Bioepis makes progress with denosumab and ranibizumab biosimilar candidates • Source: Shutterstock

More from Biosimilars

More from Products